Rashtriya Newsflash

Charcot Marie Tooth Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pharnext SA, MedDay Pharma, HELIXMITH, ENCell, Chong Kun Dang Pharm

Charcot Marie Tooth Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pharnext SA, MedDay Pharma, HELIXMITH, ENCell, Chong Kun Dang Pharm

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Charcot Marie Tooth Disease pipeline constitutes 10+ key companies continuously working towards developing 15+ Charcot Marie Tooth Disease treatment therapies,

Read Full Article

Giant-Cell Arteritis Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | AbbVie, Novartis, CSL, Kiniksa Pharma, Eli Lilly, Roche, Johnson & Johnson, MorphoSys AG

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Giant-Cell Arteritis pipeline constitutes 6+ key companies continuously working towards developing 6+ Giant-Cell Arteritis treatment therapies, analysis of Clinical Trials,

Read Full Article

Verrica’s VP-102 Advances Dermatology Care: First Patient Dosed in Global Phase 3 Common Warts Program

Verrica Pharmaceuticals doses first patient in global Phase 3 VP-102 trial for common warts, expanding beyond molluscum contagiosum treatment.   Verrica Pharmaceuticals Inc. has reached a key clinical milestone with

Read Full Article

Patty Shukla to Collaborate with Leading Australian Children’s YouTube Artists and Announce Live Appearances in Uruguay

Internationally recognized early childhood music educator and children’s artist Patty Shukla has announced upcoming international collaborations and live appearances scheduled for early 2026. Shukla will travel to Australia in March

Read Full Article

Myotonic Dystrophy Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Myotonic Dystrophy Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Myotonic Dystrophy

Read Full Article

Fibromyalgia Clinical Trial Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Fibromyalgia Pipeline Insight 2026” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Fibromyalgia pipeline landscape.

Read Full Article

Hemophagocytic Lymphohistiocytosis Clinical Trial Pipeline Shows Potential with Active Contributions from 5+ Key Companies | DelveInsight

DelveInsight’s, “Hemophagocytic Lymphohistiocytosis Pipeline Insights 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Hemophagocytic Lymphohistiocytosis

Read Full Article

Chronic Spontaneous Urticaria Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Chronic Spontaneous Urticaria Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the

Read Full Article

Automotive Diagnostic Tools Market to Reach USD 49.24 billion by 2031 – Mordor Intelligence

Automotive Diagnostic Tools Market Mordor Intelligence has published a new report on the automotive diagnostic tools market offering a comprehensive

Read Full Article

Digital Inks Market to rise at 6.13% CAGR by 2031 | DIC Corporation, Flint Group, INX International Ink Co, Siegwerk Druckfarben AG

Digital Inks Mordor Intelligence has published a new report on the Digital Inks Market, offering a comprehensive analysis of trends,

Read Full Article